Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

NCT04625907 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04625907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Lead sponsor
University of Birmingham
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 17, 2020
Completion date
June 30, 2030
Enrollment
1,672 (estimated)
Sites
128

Conditions

As the registry lists them; a condition with its own page is linked.

rhabdomyosarcoma